ZOLL Medical (ZOLL) Receives FDA Approval to Market New LifeVest Model
Down)
ZOLL Medical Corporation (Nasdaq: ZOLL) has received approval from the FDA to market and sell a new model of the LifeVest(R) wearable defibrillator.
The LifeVest wearable defibrillator is worn by patients at risk for sudden cardiac arrest (SCA), allowing their physicians time to assess their long-term arrhythmic risk and make appropriate plans, including potentially the decision to implant a cardioverter defibrillator (ICD). The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. Today over 2,000 patients are currently wearing the LifeVest.
The LifeVest wearable defibrillator is worn by patients at risk for sudden cardiac arrest (SCA), allowing their physicians time to assess their long-term arrhythmic risk and make appropriate plans, including potentially the decision to implant a cardioverter defibrillator (ICD). The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. Today over 2,000 patients are currently wearing the LifeVest.
You May Also Be Interested In
- Baxter Int'l (BAX) says low-glucose PD regimen has favorable impact on ESRD patients w/ diabetes
- IsoRay (ISR) Says GliaSite System Received CE Mark; to Go On Sale in 31 European Markets
- Syngenta (SYT) settles atrazine litigation; will pay $105M in deal
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
